We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-4.88%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$217M
AUM Growth
+$14.7M
Cap. Flow
-$10.7M
Cap. Flow %
-4.92%
Top 10 Hldgs %
31.84%
Holding
169
New
34
Increased
48
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
TGAN
Transphorm, Inc. Common Stock
TGAN
+$4.28M
2
ESS icon
Essex Property Trust
ESS
+$4.25M
3
CAMP
CalAmp Corp.
CAMP
+$2.92M
4
EOLS icon
Evolus
EOLS
+$1.72M
5
DZSI
DZS Inc. Common Stock
DZSI
+$1.72M

Top Sells

Rank Stock Value
1
LTRX icon
Lantronix
LTRX
+$1.24M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
+$1.24M
3
OIIM
02Micro International
OIIM
+$1.11M
4
FOCL
EDAP TMS S.A.
FOCL
+$1.03M
5
SPG icon
Simon Property Group
SPG
+$847K

Sector Composition

Rank Sector Weight
1 Technology 24.37%
2 Healthcare 10.03%
3 Financials 4.46%
4 Consumer Discretionary 3.02%
5 Real Estate 2.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSR
76
DELISTED
Whitestone REIT
WSR
$272K 0.13%
+20,500
New +$235K
EEFT icon
77
Euronet Worldwide
EEFT
$2.88B
$270K 0.12%
+2,078
New +$264K
ALCO icon
78
Alico
ALCO
$283M
$264K 0.12%
7,038
+1,275
+22% +$44.4K
RCUS icon
79
Arcus Biosciences
RCUS
$3.6B
$249K 0.12%
+7,900
New +$265K
JBGS
80
JBG SMITH
JBGS
$693M
$231K 0.11%
7,900
+800
+11% +$22.5K
HIW icon
81
Highwoods Properties
HIW
$3.67B
$229K 0.11%
+5,000
New +$221K
PGRE
82
DELISTED
Paramount Group
PGRE
$218K 0.1%
20,000
+6,000
+43% +$58.5K
PCSA icon
83
Processa Pharmaceuticals
PCSA
$6.12M
$214K 0.1%
142
– –
HSDT icon
84
Solana Company
HSDT
$97.5M
$207K 0.1%
2
– –
PRBM
85
DELISTED
Parabellum Acquisition Corp.
PRBM
$193K 0.09%
39,221
– –
AMRS
86
PUT
DELISTED
Amyris Inc.
AMRS
$141K 0.07%
190,100
+112,000
+143% +$503K
SIRI icon
87
SiriusXM
SIRI
$10.3B
$140K 0.06%
+2,121
New +$133K
OPEN icon
88
Opendoor
OPEN
$4.03B
$117K 0.05%
+13,954
New +$130K
AVDL
89
DELISTED
Avadel Pharmaceuticals
AVDL
$109K 0.05%
+15,900
New +$109K
CYTHW
90
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$99K 0.05%
74,736
– –
VCNX
91
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$88K 0.04%
+318
New +$87.9K
AMPG icon
92
AmpliTech
AMPG
$134M
$87K 0.04%
+25,828
New +$84.5K
NLSPW
93
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$74K 0.03%
194,560
– –
RCUS icon
94
PUT
Arcus Biosciences
RCUS
$3.6B
$68K 0.03%
+31,500
New +$1.06M
AXSM icon
95
PUT
Axsome Therapeutics
AXSM
$10.9B
$63K 0.03%
+109,800
New +$3.4M
VRM icon
96
PUT
Vroom Inc
VRM
$36.8M
$57K 0.03%
465
-109
-19% -$51.7K
AKBA icon
97
PUT
Akebia Therapeutics
AKBA
$354M
$51K 0.02%
+63,500
New +$136K
AKBA icon
98
Akebia Therapeutics
AKBA
$354M
$46K 0.02%
+63,500
New +$136K
BTAI icon
99
PUT
BioXcel Therapeutics
BTAI
$27.3M
$45K 0.02%
+1,725
New +$500K
PRBM.WS
100
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$16K 0.01%
139,072
– –
2 3
4
5 6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Worth Venture Partners held 169 positions worth $217M, up 7.3% from $202M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Worth Venture Partners withdrew a net $10.7M in Q1 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Lantronix, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Transphorm, Inc. Common Stock worth $4.31M.

  • Worth Venture Partners's largest Q1 2022 buy was Transphorm, Inc. Common Stock: 609,170 shares worth $4.31M.
  • Worth Venture Partners added most to DZS Inc. Common Stock in Q1 2022, an estimated $1.72M increase.
  • Worth Venture Partners's biggest Q1 2022 reduction was EDAP TMS S.A., cutting an estimated $1.03M.
  • Worth Venture Partners fully exited Lantronix in Q1 2022, selling an estimated $1.24M.
  • Worth Venture Partners's ten largest holdings make up 32% of its $217M portfolio in Q1 2022.
  • Worth Venture Partners opened 34 new positions and closed 23 in Q1 2022.
  • Worth Venture Partners's portfolio value rose 7.3% quarter-over-quarter to $217M.

Based on Worth Venture Partners's 13F filing for Q1 2022, filed 16 May 2022.